Abbott Laboratories Sees Q3 Adj EPS $1.38-$1.46 vs $1.42 Est

Benzinga Newsdesk www.benzinga.com Positive 59.2%

Neg 0% Neu 0% Pos 59.2%

Abbott Laboratories (NYSE:ABT) is looking for Q3 Adj EPS of $1.38-$1.46 vs $1.42 analyst estimate..

Comments

No comments yet. Be the first!